| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.326 | 3.592 | - | 0 | - | 0 | 0 | 0 | - | - |
| Total Income - EUR | 5.326 | 3.595 | - | 0 | - | 0 | 0 | 0 | - | - |
| Total Expenses - EUR | 7.510 | 7.375 | - | 0 | - | 0 | 0 | 0 | - | - |
| Gross Profit/Loss - EUR | -2.185 | -3.780 | - | 0 | - | 0 | 0 | 0 | - | - |
| Net Profit/Loss - EUR | -2.203 | -3.852 | - | 0 | - | 0 | 0 | 0 | - | - |
| Employees | 1 | 1 | - | 0 | - | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Lary & Sanda Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 31 | 0 | - | 0 | - | 0 | 0 | 0 | - | - |
| Current Assets | 2.675 | 10.559 | - | 9.616 | - | 131 | 128 | 129 | - | - |
| Inventories | 2.604 | 10.296 | - | 9.479 | - | 0 | 0 | 0 | - | - |
| Receivables | 0 | 68 | - | 0 | - | 0 | 0 | 0 | - | - |
| Cash | 71 | 195 | - | 136 | - | 131 | 128 | 129 | - | - |
| Shareholders Funds | -2.158 | -7.252 | - | -11.605 | - | -11.164 | -10.917 | -10.951 | - | - |
| Social Capital | 45 | 45 | - | 43 | - | 41 | 40 | 41 | - | - |
| Debts | 4.864 | 17.811 | - | 21.221 | - | 11.296 | 11.045 | 11.079 | - | - |
| Income in Advance | 0 | 0 | - | 0 | - | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4771 - 4771" | |||||||||
| CAEN Financial Year |
4771
|
|||||||||
Comments - Lary & Sanda Med Srl